Testing Crisugabalin for nerve pain after radiation
Treatments studied
Part of Brain & nervous system, Cancer, Pain clinical trials.
This trial tests a drug called Crisugabalin to see if it helps people with nerve pain caused by radiation treatment for head and neck cancer. The study aims to find a better way to manage this type of pain that does not go away.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had radiation for head or neck cancer at least 6 months ago
- You have nerve pain in your head, face, neck, or arms that started after radiation and has lasted at least 4 weeks
- Your pain level is at least 4 out of 10 on a pain scale over the past week
- You are at least 18 years old and expected to live at least 5 more months
- You cannot have taken pregabalin or similar drugs recently
- You do not have any other major health problems that could affect the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called Crisugabalin can reduce nerve pain in people with NMOSD. It's a 4-week trial where you could receive the study drug or a placebo (a dummy pill) — neither you nor your doctor will know which one you get.
This study looks at why some people with cancer develop nerve pain (neuropathic pain) during treatment. By tracking your health and symptoms, researchers hope to find ways to predict and prevent this side effect.
This study looks for ways to predict and improve pain you may have months after radiotherapy for first head and neck cancer. It may help doctors better anticipate pain and support patients during recovery.
This trial tests if taking gabapentin during chemoradiation for head and neck cancer can reduce the need for strong painkillers like opioids. It may help manage mouth pain caused by treatment.
This trial is testing two medications, pregabalin and crisugabalin, to see how safe and effective they are for people with fibromyalgia who have not yet tried prescription treatments. You may qualify if your pain is moderate to severe and nondrug approaches haven't helped enough.
This trial tests a new medicine called crisugabalin to see if it safely reduces shingles pain. It may help if you have moderate to severe pain from a shingles rash that started less than 3 months ago.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.